Loading
Latest filing published 29 Nov 2019 for Telo Genomics Corp., €31k.
No signal scores available.
Sabine Mai discloses dealings in Telo Genomics Corp. to SEDI. The record holds 2 filings, for trades running from 25 November 2019 to 26 November 2019.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 29 November 2019 came the latest disclosure, a share grant for €31k in Telo Genomics Corp. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations